Early Responses to Intravitreal Ranibizumab in Typical Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy

<table>Changes in central retinal thickness (CRT) for tAMD and PCV patients after intravitreal ranibizumab. Diamonds with dashed lines: tAMD; squares with solid lines: PCV. Values represent means ± SEM.</table>

Journal of Ophthalmology

fig2

Figure 2

Figure 2: Early Responses to Intravitreal Ranibizumab in Typical Neovascular Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy 